T604-0163 Screening compound: 5-(2-hydroxyethyl)-6-methyl-3-{[5-methyl-2-(4-methylphenyl)-1,3-oxazol-4-yl]methyl}-2-phenyl-3,4-dihydropyrimidin-4-one

T604-0163 Screening compound: 5-(2-hydroxyethyl)-6-methyl-3-{[5-methyl-2-(4-methylphenyl)-1,3-oxazol-4-yl]methyl}-2-phenyl-3,4-dihydropyrimidin-4-one
T604-0163 Screening compound: 5-(2-hydroxyethyl)-6-methyl-3-{[5-methyl-2-(4-methylphenyl)-1,3-oxazol-4-yl]methyl}-2-phenyl-3,4-dihydropyrimidin-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound T604-0163
5-(2-hydroxyethyl)-6-methyl-3-{[5-methyl-2-(4-methylphenyl)-1,3-oxazol-4-yl]methyl}-2-phenyl-3,4-dihydropyrimidin-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T604-0163

Molecular Formula

C25H25N3O3 (C25 H25 N3 O3)

Compound Name

5-(2-hydroxyethyl)-6-methyl-3-{[5-methyl-2-(4-methylphenyl)-1,3-oxazol-4-yl]methyl}-2-phenyl-3,4-dihydropyrimidin-4-one

IUPAC name

5-(2-hydroxyethyl)-6-methyl-3-{[5-methyl-2-(4-methylphenyl)-13-oxazol-4-yl]methyl}-2-phenyl-34-dihydropyrimidin-4-one

SMILES

Cc1c(CN(C(c2ccccc2)=NC(C)=C2CCO)C2=O)nc(-c2ccc(C)cc2)o1

InChI

InChI=1S/C25H25N3O3/c1-16-9-11-20(12-10-16)24-27-22(18(3)31-24)15-28-23(19-7-5-4-6-8-19)26-17(2)21(13-14-29)25(28)30/h4-12,29H,13-15H2,1-3H3

InChI Key

CIJXSLDLZIXIFM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD28998865

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

415.49

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.380

Distribution Coefficient, logD

3.379

Water Solubility, LogSw

-3.37

Polar Surface Area

59.779

Acid Dissociation Constant (pKa)

15.18

Base Dissociation Constant (pKb)

4.59

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.00

T604-0163 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

Bromodomain Modulators Library (5801 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with T604-0163 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T604-0163?
Check Price and Availability of T604-0163, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T604-0163 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T604-0163
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T604-0163
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T604-0163 available by request